The largest database of trusted experimental protocols

Bay11 7085

Manufactured by Apexbio
Sourced in Colombia

BAY11-7085 is a chemical compound that is used in laboratory research. It functions as an inhibitor of the activation of the nuclear factor-kappa B (NF-κB) signaling pathway. This pathway is involved in the regulation of various cellular processes, including inflammation and immune responses.

Automatically generated - may contain errors

2 protocols using bay11 7085

1

Signaling Pathway Inhibitors in Ringer's

Check if the same lab product or an alternative is used in the 5 most similar protocols
DIOA, #D129 SigmaAldrich.Bumetanide, #B3023 Sigma Aldrich.Staurosporine, #sc3510A Santa Cruz Biotechnology.Go6983, #G1918 SigmaAldrich.BAY11-7085, #B3033 APExBio.VU0463271, #4719 Tocris. All inhibitors were applied in Ringer’s solution at concentrations and incubation times shown in the relevant figure legend.
+ Open protocol
+ Expand
2

Evaluating Gefitinib, Erlotinib, and Cetuximab Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a density of 10,000 cells/well in a 96-well plate and allowed to attach for eight hours prior to drug treatment. For viability testing, cells were treated with 5 μM gefitinib (#076091; Matrix Scientific, Columbia, SC), 10 μM erlotinib (#10483; Cayman Chemical; Ann Arbor, MI), or 10 nM cetuximab (#NBP2-75903; Novus Biologicals; Centennial, CO), with or without BAY 11–7085 (#B3033; ApexBio Technology; Houston, TX) at 2 μM or 3.3 μM for 48 hours. DMSO vehicle controls were included. For all treatments the final DMSO concentration was 1%. After 48 hours cell viability was assessed using the MTS assay (Biovision; Milpitas, CA) as previously described [35 (link)]. Viability was calculated by normalizing each cell line to vehicle treatment alone.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!